|
WO2020230838A1
|
|
Method for administering oncolytic virus to tumor tissue, and device for administration
|
|
EP2228373A1
|
|
METHOD FOR PRODUCING 4'-ETHYNYL d4T
|
|
WO2008136213A1
|
|
Radiosensitivity-enhancing agent
|
|
US2009181931A1
|
|
Antiviral activity of cidofovir against oncolytic viruses
|
|
WO2008065726A1
|
|
Telomelysin-containing agent for breaking antitumor tolerance
|
|
EP1859804A1
|
|
Anticancer agent combination therapy
|
|
CN101232894A
|
|
Anticancer agent to be combined with telomelysin
|
|
JP2007015997A
|
|
Telomelysin-containing agent overcoming antitumor agent resistance
|
|
US2006067890A1
|
|
Telomelysin/GFP-expressing recombinant virus
|
|
US7038028B1
|
|
Gene encoding promoter domain of tumor suppressor gene P51 and use thereof
|
